These kidney pathologies are associated with basic fibroblast growth factor (FGF2), an important cytokine which facilitates renal matrix formation (Strutz et al., 2001; Mattison et al., 2012; Bozic et al., 2018). This evidence concerns the gene FGF2 and urogenital neoplasm.